Economic analyses to inform public health decision-making for tuberculosis: the role of understanding implementation

被引:2
作者
Shete, Priya B. [1 ,2 ]
Kahn, James G. [2 ,3 ]
机构
[1] Univ Calif San Francisco, Div Pulm & Crit Care Med, Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Inst Hlth Policy Studies, Consortium Assess Prevent Econ, 3333 Calif Ave, San Francisco, CA 94118 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94158 USA
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
Tuberculosis; Cost effectiveness; Public health system; MTB/RIF; COST;
D O I
10.1186/s12916-019-1468-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 10 条
  • [1] Evaluating the public health impact of health promotion interventions: The RE-AIM framework
    Glasgow, RE
    Vogt, TM
    Boles, SM
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (09) : 1322 - 1327
  • [2] How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations
    Hauck, K.
    Morton, A.
    Chalkidou, K.
    Chi, Y-Ling
    Culyer, A.
    Levin, C.
    Meacock, R.
    Over, M.
    Thomas, R.
    Vassall, A.
    Verguet, S.
    Smith, P. C.
    [J]. SOCIAL SCIENCE & MEDICINE, 2019, 220 : 141 - 149
  • [3] Higher cost of implementing Xpert® MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness
    Hsiang, E.
    Little, K. M.
    Hagurna, P.
    Hanrahan, C. F.
    Katamba, A.
    Cattamanchi, A.
    Davis, J. L.
    Vassall, A.
    Dowdy, D.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (09) : 1212 - 1218
  • [4] The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals
    Loennroth, Knut
    Raviglione, Mario
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2016, 110 (03) : 148 - 150
  • [5] Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
    Pooran, Anil
    Theron, Grant
    Zijenah, Lynn
    Chanda, Duncan
    Clowes, Petra
    Mwenge, Lawrence
    Mutenherwa, Farirai
    Lecesse, Paul
    Metcalfe, John
    Sohn, Hojoon
    Hoelscher, Michael
    Pym, Alex
    Peter, Jonny
    Dowdy, David
    Dheda, Keertan
    [J]. LANCET GLOBAL HEALTH, 2019, 7 (06): : E798 - E807
  • [6] Stakeholder perspectives on costs and resource expenditures: tools for addressing economic issues most relevant to patients, providers, and clinics
    Rhodes, Whitney C. Jones
    Ritzwoller, Debra P.
    Glasgow, Russell E.
    [J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2018, 8 (05) : 675 - 682
  • [7] Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model
    Sohn, Hojoon
    Kasaie, Parastu
    Kendall, Emily
    Gomez, Gabriela B.
    Vassall, Anna
    Pai, Madhukar
    Dowdy, David
    [J]. BMC MEDICINE, 2019, 17 (01)
  • [8] United Nations General Assembly, 2018, UN END TUB URG GLOB
  • [9] WHO's new End TB Strategy
    Uplekar, Mukund
    Weil, Diana
    Lonnroth, Knut
    Jaramillo, Ernesto
    Lienhardt, Christian
    Dias, Hannah Monica
    Falzon, Dennis
    Floyd, Katherine
    Gargioni, Giuliano
    Getahun, Haileyesus
    Gilpin, Christopher
    Glaziou, Philippe
    Grzemska, Malgorzata
    Mirzayev, Fuad
    Nakatani, Hiroki
    Raviglione, Mario
    [J]. LANCET, 2015, 385 (9979) : 1799 - 1801
  • [10] World Health Organization, 2023, GLOBAL TUBERCULOSIS